healthcare -sector presentation - health care...healthcare -sector presentation 02/25/2014 ......
TRANSCRIPT
HealthCare -Sector Presentation 02/25/2014 By Le Zhao, Stephanie Zimmerman,
Xiongyi Zheng and Zhen Zhang
Agenda
Overview
Sector
Weights
Key Players
Relation with S&P 500
Financial Analysis
Business Environment
ACA
Recommendation
Overview
Fundamentals AS OF 02/21/2014
Market Cap $4.13T
P/E (Last Year GAAP Actual) 31.92
P/E (This Year's Estimate) 29.46
Enterprise Value $97.00B
EPS (TTM) $2.79
EPS Growth (TTM vs. Prior TTM) -48.13%
Revenue Growth (TTM vs. Prior TTM) 28.16%
Return on Equity (TTM) 16.63%
Return on Investment (TTM) 10.19%
Total Debt/Equity (TTM) 56.57
Dividend Yield 2.42%
Sector
28%
72%
0% 20% 40% 60% 80%
Health CareEquipment &
Services
Pharmaceuticals &Biotechnology
Health Care Industry
12%
12%
4%
21%
51%
0% 10% 20% 30% 40% 50% 60%
Health Care Providers
Medical Equipment
Medical Supplies
Biotechnology
Pharmaceuticals
Health Care Sub-Industry
Weights
CONS DISCRET
12.32%
CONS STAPLES
9.46%
ENERGY
10.13%
FINANCIALS
15.92%
HEALTH
CARE
13.75%
INDUSTRIALS
10.72%
INFO TECH
18.93%
MATERIALS
3.52%
TELECOM SERV
2.23% UTILITIES
3.03%
Weights in S&P 500
CONS DISCRET
13.24%
CONS STAPLES
9.47%
ENERGY
8.91%
FINANCIALS
15.83%
HEALTH
CARE
14.04%
INDUSTRIALS
8.69%
INFO TECH
20.30%
MATERIALS
3.05%
TELECOM SERV
1.20%
UTILITIES
3.43% Cash
1.78% Dividend
Receivables
0.06%
Weights in SIM
# Name Ticker MktCapUSD
1 Johnson & Johnson JNJ US 258.56B
2 Pfizer Inc. PFE US 204.02B
3 Merck & Co. Inc. MRK US 160.82B
4 Gilead Sciences Inc. GILD US 126.90B
5 Amgen Inc. AMGN US 93.13B
6 Bristol-Myers Squibb Company BMY US 88.22B
7 AbbVie Inc. ABBV US 81.44B
8 Biogen Idec Inc. BIIB US 77.64B
9 UnitedHealth Group Incorporated UNH US 72.76B
10 Celgene Corporation CELG US 66.18B
Key Players
Relation with S&P 500
Correlation=0.97
-50.00%
-30.00%
-10.00%
10.00%
30.00%
50.00%
70.00%
90.00%
110.00%
130.00%
150.00%
S&P 500 Index (^SPX) - Index Value S&P 500 Sector Indices - Health Care Sector Index (^HCX) - Index Value
Regression Detail
HCX=-0.107234669979407+1.07148688439782*SPX
SUMMARY OUTPUT
Regression Statistics
Multiple R 0.969289849
R Square 0.939522811
Adjusted R Square 0.939475966
Standard Error 0.077901167
Observations 1293
ANOVA
df SS MS F Significance F
Regression 1 121.7110218 121.7110218 20055.89172 0
Residual 1291 7.834552127 0.006068592
Total 1292 129.5455739
Coefficients Standard Error t Stat P-value Lower 95% Upper 95% Lower 95.0% Upper 95.0%
Intercept -0.10723467 0.003893602 -27.5412542 9.8399E-132 -0.11487315 -0.09959619 -0.11487315 -0.09959619
X Variable 1 1.071486884 0.007565992 141.6188255 0 1.056643897 1.086329872 1.056643897 1.086329872
Financial Analysis – ToRe1yr Total Return 1 Year Average Median Std Dev High Low
All Sectors 30.49 14.95 77.4 622.39 -100
Basic Materials 21.54 -0.59 58.55 225 -99.87
Consumer Goods 24.12 13.58 73.3 400 -99.63
Consumer Services 35.46 21.28 79.22 616.67 -100
Financials 24.48 13.28 76.44 860 -99.99
Health Care 51.48 18.17 88.04 398.69 -100
Industrials 30.13 18.36 56.63 257.14 -100
Oil & Gas 16.28 5.31 70.16 449.59 -98.13
Technology 36.9 19.72 88.88 575 -99.97
Telecommunications 16.28 18.55 105.64 466.15 -99.61
Utilities 15.15 12.79 19.3 80.28 -60.62
Total Return 1 Year Average Median Std Dev High Low
Health Care 39.88 30.83 31.68 116.34 -24.44
Pharmaceuticals &
Biotechnology 48.22 49.22 46.19 158.61 -11.34
Health Care Equipment &
Services 30.4 25.31 23.63 74.13 -24.44
Financial Analysis – ToRe 3m Total Return 1 Quarter Average Median Std Dev High Low
All Sectors 5.52 2.94 35.88 260 -99.05
Basic Materials 5.64 3.22 55.9 409.8 -90
Consumer Goods 0.15 0 29.28 143.75 -92.13
Consumer Services 3.39 -0.53 46.53 366.67 -94.82
Financials 3.52 2.12 26.34 159.85 -96.8
Health Care 13.49 12.27 43.11 221.68 -99.05
Industrials 3.67 2.5 28.57 160 -92
Oil & Gas 2.06 1.66 44.65 333.33 -97.96
Technology 11.84 7.1 34.8 248.39 -98.01
Telecommunications -1.86 4.39 63.2 409.09 -77.98
Utilities 4.45 3.53 14.55 90.14 -55.56
Total Return 1 Quarter Average Median Std Dev High Low
Health Care 8.43 6.63 11.26 33.81 -13.73
Pharmaceuticals &
Biotechnology 10.3 14.27 14.87 52.31 -5.1
Health Care Equipment &
Services 6.4 5.65 9.23 21.37 -13.73
Relative Valuation - Sector
Ticker Name P/B P/E
S5UTIL S&P 500 UTILITIES INDEX 1.614478424 16.64157999
S5TELS S&P 500 TELECOM SERV IDX 2.280880105 16.05865517
S5MATR S&P 500 MATERIALS INDEX 2.901400065 18.43976655
S5INFT S&P 500 INFO TECH INDEX 3.755710509 17.93875737
S5INDU S&P 500 INDUSTRIALS IDX 3.189900076 17.73945484
S5HLTH S&P 500 HEALTH CARE IDX 3.799800557 20.13685007
S5FINL S&P 500 FINANCIALS INDEX 1.303102887 13.19363525
S5ENRS S&P 500 ENERGY INDEX 1.966284176 14.60190889
S5CONS S&P 500 CONS STAPLES IDX 4.315422193 17.92531647
S5COND S&P 500 CONS DISCRET IDX 4.271540392 20.4955769
Relative Valuation - Industry P/B Average Median Std Dev High Low
Pharmaceuticals &
Biotechnology 5.87 5.11 5.17 17.78 2.46
Health Care Equipment &
Services 3.05 2.94 1.34 5.55 1.05
P/E Average Median Std Dev High Low
Pharmaceuticals &
Biotechnology 29.24 29.24 33.43 125.44 13.13
Health Care Equipment &
Services 19.15 19.72 5.84 33 9.7
Ticker Name P/B P/E Industry Sub-Industry
GILD Gilead 10.732 43.8361 Biotech & Pharma Biotech
TEVA Teva Pharamceuticals - 10.822Est Biotech & Pharma Generic Pharmaceuticals
ACT Actavis PLC 3.9859 50.3317 Biotech & Pharma Generic Pharmaceuticals
MYL Mylan Inc 6.1802 30.0365 Biotech & Pharma Generic Pharmaceuticals
AET Aetna 1.9006 12.0244 Health Care Facilities/Srvcs Managed Care
MCK McKesson Corp 5.053 24.9471 Health Care Facilities/Srvcs Health Care Facility Chain
COV Covidien PLC 3.3996 17.9897 Medical Equipment/Devices Medical Equipment
STJ St. Jude Medical Inc 3.5235 17.7983 Medical Equipment/Devices Cardiovascular Devices
Business Environment
Business Cycle
Business Environment
- Opportunities & Threats
Power of Suppliers
Power of Buyers
Threat of Substitutes
Industry Competition
Threat of entry
Business Environment
–Population Trend
After ACA Implementation
The 80/20 Rule of ACA.
What Does This Mean the
Health Care Sector?
More Individuals will be entering into the health care market
and access to health care products such as pharmaceuticals
will increase.
There will be a greater distribution of revenues and costs as
young adults sign up for health care.
Higher Premiums will be seen as health care companies pass
on incurred costs of ACA onto consumers.
Health Care companies are shifting fees and taxes by the
government back onto tax payers
SIM Portfolio Jan 2014 TEVA
GILD
Recommendation
Q&A